Risk of surgical site infection, acute kidney injury, and infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study

1. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283. doi: 10.2146/ajhp120568 23327981

2. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004;38(10):1357–63. doi: 10.1086/383318 15156470

3. Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis? Clin Infect Dis. 2012;54(10):1474–9. doi: 10.1093/cid/cis027 22328468

4. Gupta K, Strymish J, Abi-Haidar Y, Williams SA, Itani KM. Preoperative nasal methicillin-resistant Staphylococcus aureus status, surgical prophylaxis, and risk-adjusted postoperative outcomes in veterans. Infect Control Hosp Epidemiol. 2011;32(8):791–6. doi: 10.1086/660362 21768763

5. Miller LG, McKinnell JA, Vollmer ME, Spellberg B. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol. 2011;32(4):342–50. doi: 10.1086/658668 21460485

6. Bull AL, Worth LJ, Richards MJ. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS). Ann Surg. 2012;256(6):1089–92. doi: 10.1097/SLA.0b013e31825fa398 22824854

7. Sewick A, Makani A, Wu C, O’Donnell J, Baldwin KD, Lee GC. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? Clin Orthop Relat Res. 2012;470(10):2702–7. doi: 10.1007/s11999-012-2255-1 22290130

8. Schweizer ML, Chiang HY, Septimus E, Moody J, Braun B, Hafner J, et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA. 2015;313(21):2162–71. doi: 10.1001/jama.2015.5387 26034956

9. Courtney PM, Melnic CM, Zimmer Z, Anari J, Lee GC. Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty. Clin Orthop Relat Res. 2015;473(7):2197–203. doi: 10.1007/s11999-014-4062-3 25421958

10. Kim T, Kandiah S, Patel M, Rab S, Wong J, Xue W, et al. Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy. BMC Res Notes. 2015;8 : 579. doi: 10.1186/s13104-015-1518-9 26476979

11. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S19–31.

12. Henderson WG, Daley J. Design and statistical methodology of the National Surgical Quality Improvement Program: why is it what it is? Am J Surg. 2009;198(5):S19–27.

13. Acute Kidney Injury Network. AKIN studies. 2016. Available from: http://www.akinet.org/akinstudies.php. Accessed 2017 Jun 8.

14. Crump RK, Hotz VJ, Imbens GW, Mitnik OA. Dealing with limited overlap in estimation of average treatment effects. Biometrika. 2009;96(1):187–99.

15. Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution—a simulation study. Am J Epidemiol. 2010;172(7):843–54. doi: 10.1093/aje/kwq198 20716704

16. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200. doi: 10.1093/aje/kwi188 15987728

17. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6. 15033648

18. Petersen MR, Deddens JA. A comparison of two methods for estimating prevalence ratios. BMC Med Res Methodol. 2008;8(1):9.

19. Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013;346:f2743. doi: 10.1136/bmj.f2743 23766464

20. Grigg C, Baggs J, Jernigan J, editors. Association between surgical antimicrobial prophylaxis regimen and risk of mediastinitis following coronary artery bypass grafting. Open Forum Infect Dis. 2015;2(Suppl 1):1261.

21. Nickinson R, Board T, Gambhir A, Porter M, Kay P. The microbiology of the infected knee arthroplasty. Int Orthop. 2010;34(4):505–10. doi: 10.1007/s00264-009-0797-y 19458950

22. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302–45. doi: 10.1128/CMR.00111-13 24696437

23. Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, et al. Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation. Clin Microbiol Infect. 2015;21(7):674.e11–8.

24. Malani PN. Bundled approaches for surgical site infection prevention: the continuing quest to get to zero. JAMA. 2015;313(21):2131–2. doi: 10.1001/jama.2015.6018 26034954

25. Bateman BT, Rassen JA, Schneeweiss S, Bykov K, Franklin JM, Gagne JJ, et al. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2013;146(2):472–8. doi: 10.1016/j.jtcvs.2013.02.075 23541855

26. Poeran J, Mazumdar M, Rasul R, Meyer J, Sacks HS, Koll BS, et al. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2016;151(2):589–97.e2. doi: 10.1016/j.jtcvs.2015.09.090 26545971

27. Anderson DJ, Hartwig MG, Pappas T, Sexton DJ, Kanafani ZA, Auten G, et al. Surgical volume and the risk of surgical site infection in community hospitals: size matters. Ann Surg. 2008;247(2):343–9. doi: 10.1097/SLA.0b013e31815aab38 18216543

28. Meyer E, Weitzel-Kage D, Sohr D, Gastmeier P. Impact of department volume on surgical site infections following arthroscopy, knee replacement or hip replacement. BMJ Qual Saf. 2011;20(12):1069–74. doi: 10.1136/bmjqs.2011.051250 21768211

29. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis. 2011;53(2):144–9. doi: 10.1093/cid/cir308 21690621

30. RAND Corporation. Assessment A (demographics). Washington (DC): Department of Veterans Affairs; 2015. Available from: https://www.va.gov/opa/choiceact/documents/assessments/Assessment_A_Demographics.pdf. Accessed 2017 Jun 21.

31. Department of Veterans Affairs. Methicillin-resistant Staphylococcus aureus (MRSA) prevention initiative. Washington (DC): Department of Veterans Affairs; 2010. VHA Directive 2010–006.

32. Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther. 2012;34(1):149–57. doi: 10.1016/j.clinthera.2011.12.013 22284995

33. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916–21. 10869263

34. PLoS Medicine Editors. Ensuring integrity in comparative effectiveness research: accentuate the negative. PLoS Med. 2009;6(9):e1000152. doi: 10.1371/journal.pmed.1000152 19787024